Rituximab hypersensitivity in IgG4-related disease: successful desensitization in a patient with IgG4 rheumatoid factor
- 30 December 2016
- journal article
- case report
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 20 (2), 276-279
- https://doi.org/10.1111/1756-185x.13021
Abstract
No abstract availableFunding Information
- Fondazione Italiana per la Ricerca sul Cancro
This publication has 10 references indexed in Scilit:
- Immunology of IgG4-related diseaseClinical and Experimental Immunology, 2015
- Rituximab for IgG4-related disease: a prospective, open-label trialAnnals Of The Rheumatic Diseases, 2015
- B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related diseaseAnnals Of The Rheumatic Diseases, 2014
- In Vitro Diagnosis of Delayed-type Drug HypersensitivityImmunology and Allergy Clinics of North America, 2014
- De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related diseaseJournal of Allergy and Clinical Immunology, 2014
- IgM rheumatoid factor amplifies the inflammatory response of macrophages induced by the rheumatoid arthritis-specific immune complexes containing anticitrullinated protein antibodiesAnnals Of The Rheumatic Diseases, 2014
- Adverse reactions in patients with B‐cell lymphomas during combined treatment with rituximab: In vitro evaluation of rituximab hypersensitivity by basophil activation testAmerican Journal of Hematology, 2012
- Development of an IgG4-RD Responder IndexInternational Journal of Rheumatology, 2012
- Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatmentJournal of Allergy and Clinical Immunology, 2009
- IgG-dependent activation of human mast cells following up-regulation of FcγRI by IFN-γEuropean Journal of Immunology, 2001